Bezmialem Vakıf University
Istanbul, Fatih, 34093, Turkey (Türkiye)
NCT Number: NCT06176612
Patients with developmental hip dysplasia often present to the outpatient clinic in adulthood with hip pain due to progressive hip osteoarthritis. However, they may have complaints such as limping, lumbar lordosis, lower back pain, and leg length difference. Today, the best treatment option for these patients is hip arthroplasty. Hip arthroplasty causes a high rate of functional improvement and pain relief. According to the hip arthroplasty technique applied, improvement in lameness, leg length difference and spinal curvatures is expected. The aim of our study is to show the change in postoperative spine and lower extremity curvatures after hip arthroplasty in patients with advanced developmental hip dislocation.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Istanbul, Fatih, 34093, Turkey (Türkiye)
Developmental hip dysplasia (DDH) describes the spectrum of anatomical changes in the acetabulum and proximal femur; these can cause limping, lower back pain, lumbar lordosis, and leg length variation. DDH is the main cause of degenerative arthritis of the hip and valgus deformity of the knee. The best treatment option for DDH is total hip arthroplasty (THA). During THA, the distorted anatomy of the acetabulum and proximal femur poses great difficulties. Additionally, the soft tissue can be released and the femur can be shortened while correcting the placement of the acetabulum to prevent neurological damage (sciatic nerve paralysis). Postoperative evaluations focused on assessing joint function and alleviating preoperative clinical symptoms. Some studies have examined changes in lower extremity and knee alignment after THA in patients with DDH. In patients with DDH, THA may cause genu valgus deformity due to increased lower extremity length and Q angle immediately after the operation. THA extends the lower extremity, affecting the patellofemoral joint and anterior knee pain. However, the long-term effects of THA on the alignment of the lower extremity are unclear, especially in patients with Crowe type III and IV DDH, which involves femoral shortening osteotomy. There are few studies examining changes in the knee and lower extremities as a result of THA in patients with DDH. The aim of this study is to evaluate the mid- and long-term alignment of the spine and lower extremity after THA with or without femoral shortening osteotomy in patients with unilateral DDH (Crowe type III-IV).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients with Crowe type 3 or Crowe type 4 hip dysplasia who underwent hip replacement
Time frame: From enrollment to the end of treatment at 2 years
the lower limb was defined as the distance from the center of the knee to the mechanical axis of the lower limb
Time frame: From enrollment to the end of treatment at 2 years
the angle formed by the line from the center of the femoral canal to the center of the knee joint and the line from the center of the knee joint to the center of the ankle joint.
Time frame: From enrollment to the end of treatment at 2 years
the vertical distances from the center of the femoral head to the center of the femoral canal
Time frame: From enrollment to the end of treatment at 2 years
the angle formed by the mechanical axis of the femur and the mechanical axis of the tibia
Time frame: From enrollment to the end of treatment at 2 years
the angle formed by the anatomic axis of the femur and the distal femoral joint orientation line
Time frame: From enrollment to the end of treatment at 2 years
the angle formed by the anatomic axis of the tibia and the proximal tibial joint orientation line
Bezmialem Vakif University
Other
In Patients With Crowe Type III and Crowe Type IV Hip Dysplasia, Mid-Term Lower Extremities and Spine After Total Hip Arthroplasty Natural Course
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05186168
Arthritis, Avascular Necrosis of the Femoral Head
View Trial DetailsNCT05530551
Arthritis, Joint Diseases
Aabenraa, Denmark
View Trial DetailsNCT03789266
Drain Insertion Site, Total Hip Arthroplasty
Rouen, France
View Trial DetailsNCT07610863
Coagulation Monitoring Using ROTEM, Perioperative Blood Loss
Brno, Czechia
View Trial Details